The prognostic role of C-reactive protein in patients with head and neck squamous cell carcinoma: A meta-analysis.

Our meta-analysis demonstrated that an elevated pretreatment of CRP indicates poor prognosis in HNSCC. Therefore, CRP is an indicator of the prognosis of patients with HNSCC and can be recommended for assessing prognoses in clinical work.